The Moment that KRAS Mutation Started to Evolve into Precision Medicine in Metastatic Colorectal Cancer

被引：5
|
作者：
Ushijima, Toshikazu [1 ]
Yoshino, Takayuki [2 ]
机构：
[1] Natl Canc Ctr, Div Epigen, Res Inst, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan
[2] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan
来源：
CANCER RESEARCH | 2016年 / 76卷 / 22期
关键词：
ANTI-EGFR THERAPY; RAS MUTATIONS; ACQUIRED-RESISTANCE; CETUXIMAB THERAPY; PANITUMUMAB; EVOLUTION;
D O I：
10.1158/0008-5472.CAN-16-2867
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6443 / 6444
页数：2
相关论文
共 50 条
  • [1] Precision medicine in metastatic colorectal cancer: targeting KRAS G12C mutation
    Aparicio, Jorge
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 9
  • [2] KRAS mutation testing in metastatic colorectal cancer
    Cong Tan
    World Journal of Gastroenterology, 2012, (37) : 5171 - 5180
  • [3] KRAS mutation testing in metastatic colorectal cancer
    Tan, Cong
    Du, Xiang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (37) : 5171 - 5180
  • [4] KRAS, a New Target for Precision Medicine in Colorectal Cancer?
    Boileve, Alice
    Smolenschi, Cristina
    Lambert, Aurelien
    Boige, Valerie
    Delaye, Matthieu
    Camilleri, Geraldine M.
    Tarabay, Anthony
    Valery, Marine
    Fuerea, Alina
    Pudlarz, Thomas
    Mathieu, Jacques R. R.
    Jaulin, Fanny
    Hollebecque, Antoine
    Ducreux, Michel
    CANCERS, 2024, 16 (20)
  • [5] Advances in KRAS mutation inhibition in metastatic colorectal cancer
    Chunhua Wu
    Wenfei Li
    Mifen Chen
    Qi Zhang
    Ting Xu
    Yao Ma
    Wanyi Liu
    Zhenghang Wang
    Xicheng Wang
    Jian Li
    Tanios Bekaii-Saab
    Lin Shen
    Holistic Integrative Oncology, 2 (1):
  • [6] Comparison of methodologies for KRAS mutation detection in metastatic colorectal cancer
    Pinto, Pedro
    Rocha, Patricia
    Veiga, Isabel
    Guedes, Joana
    Pinheiro, Manuela
    Peixoto, Ana
    Pinto, Carla
    Fragoso, Maria
    Sanches, Evaristo
    Araujo, Antonio
    Alves, Fernando
    Coutinho, Camila
    Lopes, Paula
    Henrique, Rui
    Teixeira, Manuel R.
    CANCER GENETICS, 2011, 204 (08) : 439 - 446
  • [7] Implications of KRAS mutation status for the treatment of metastatic colorectal cancer
    Ciardiello, Fortunato
    Tejpar, Sabine
    Papamichael, Demetris
    TARGETED ONCOLOGY, 2009, 4 (04) : 311 - 322
  • [8] Impact of KRAS Mutation on Outcome of Patients with Metastatic Colorectal Cancer
    Chang, Yu-Yao
    Lin, Jen-Kou
    Lin, Tzu-Chen
    Chen, Wei-Shone
    Jiang, Jeng-Kai
    Yang, Shung-Haur
    Wang, Huann-Sheng
    Lan, Yuan-Tzu
    Lin, Chun-Chi
    Liang, Wen-Yih
    Chang, Shih-Ching
    HEPATO-GASTROENTEROLOGY, 2014, 61 (135) : 1946 - 1953
  • [9] Implications of KRAS mutation status for the treatment of metastatic colorectal cancer
    Fortunato Ciardiello
    Sabine Tejpar
    Demetris Papamichael
    Targeted Oncology, 2009, 4 : 311 - 322
  • [10] Precision medicine for metastatic colorectal cancer: an evolving era
    Guler, Irem
    Askan, Gokce
    Klostergaard, Jim
    Sahin, Ibrahim Halil
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (10) : 919 - 931
12345